Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Coleman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Hospitals & Health Networks|October 17, 2003
Unearth unflattering into?Dan Coleman, Preston Gee
Journal of Analytical Toxicology|May 19, 2021
Unusually High Concentration of Fentanyl in a Driver: A Case ReportDani C Mata, Dan Coleman
Journal of Analytical Toxicology|September 16, 2021
Driving under the Influence of Flualprazolam: 11 Case ReportsNicholas Mercurio, Craig Triebold, Dan Coleman
Journal of Analytical Toxicology|October 23, 2021
Erratum to: Driving under the Influence of Flualprazolam: 10 Case ReportsNicholas Mercurio, Craig Triebold, Dan Coleman
Leukemia|March 9, 2023
RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia developmentSarah A Carratt, Garth L Kong, Cody Coblentz, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Hospitals & Health Networks|October 17, 2003
Unearth unflattering into?Dan Coleman, Preston Gee
Journal of Analytical Toxicology|May 19, 2021
Unusually High Concentration of Fentanyl in a Driver: A Case ReportDani C Mata, Dan Coleman
Journal of Analytical Toxicology|September 16, 2021
Driving under the Influence of Flualprazolam: 11 Case ReportsNicholas Mercurio, Craig Triebold, Dan Coleman
Journal of Analytical Toxicology|October 23, 2021
Erratum to: Driving under the Influence of Flualprazolam: 10 Case ReportsNicholas Mercurio, Craig Triebold, Dan Coleman
Leukemia|March 9, 2023
RUNX1::ETO translocations must precede CSF3R mutations to promote acute myeloid leukemia developmentSarah A Carratt, Garth L Kong, Cody Coblentz, et al.
Pageof 1